Veracyte (VCYT) P/E (2013 - 2026)
Veracyte (VCYT) P/E from Oct 30, 2013 to Jun 3, 2026. The TTM Veracyte (VCYT) P/E is 43.94. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Veracyte (VCYT)
| Year | P/E | Change |
|---|---|---|
| 2026 | 43.94 | -12.51% |
| 2025 | 50.22 | -60.47% |
| 2024 | 127.06 | -417.09% |
| 2023 | -40.07 | +2.19% |
| 2022 | -39.21 | +5.04% |
| 2021 | -37.33 | -49.49% |
| 2020 | -73.90 | -30.35% |
| 2019 | -106.11 | +435.62% |
| 2018 | -19.81 | +141.45% |
| 2017 | -8.20 | +33.14% |
| 2016 | -6.16 | +9.66% |
| 2015 | -5.62 | -22.17% |
| 2014 | -7.22 | -50.38% |
| 2013 | -14.55 | N/A |
Comparison Veracyte (VCYT) P/E with competitors
Veracyte (VCYT) P/E is 43.94.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 0.78 | -98.23% |
| MBAI | CheckCap Ltd | 2.88 | -93.44% |
| FONR | Fonar Corp | 15.41 | -64.92% |
| QGEN | Qiagen NV | 17.55 | -60.07% |
| IQV | IQVIA Holdings Inc | 20.25 | -53.92% |
| DGX | Quest Diagnostics Inc | 21.62 | -50.80% |
| LH | Laboratory Corp Of America Holdings | 22.66 | -48.43% |
| A | Agilent Technologies Inc | 25.45 | -42.08% |
| MEDP | Medpace Holdings Inc | 26.32 | -40.09% |
| TMO | Thermo Fisher Scientific Inc | 26.87 | -38.85% |
| MTD | Mettler-Toledo International Inc | 26.96 | -38.64% |
| DHR | Danaher Corp | 33.26 | -24.32% |
| ILMN | Illumina Inc | 34.97 | -20.41% |
| ICLR | Icon Plc | 39.55 | -10.00% |
| IDXX | Idexx Laboratories Inc | 40.14 | -8.66% |
| RVTY | Revvity Inc | 45.79 | +4.21% |
| SHC | Sotera Health Company | 63.43 | +44.35% |
| WAT | Waters Corp | 93.81 | +113.48% |